Entrada Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Entrada Therapeutics Total Assets Growth & History (TRDA)
Entrada Therapeutics's total assets was $377.4M for fiscal 2025.
View full Entrada Therapeutics company overviewEntrada Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $377.4M | −$148.9M | −28.30% |
| 2024 | 2024-12-31 | $526.3M | $57.1M | +12.18% |
| 2023 | 2023-12-31 | $469.2M | $217.1M | +86.15% |
| 2022 | 2022-12-31 | $252.1M | −$53.8M | −17.58% |
| 2021 | 2021-12-31 | $305.8M | $262.3M | +602.63% |
| 2020 | 2020-12-31 | $43.5M | — | — |
Entrada Therapeutics quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $298.9M | −$149.9M | −33.40% |
| Q1 2026 | 2026-03-31 | $335.5M | −$151.0M | −31.03% |
| Q4 2025 | 2025-12-31 | $377.4M | −$148.9M | −28.30% |
| Q3 2025 | 2025-09-30 | $412.9M | −$141.7M | −25.55% |
| Q2 2025 | 2025-06-30 | $448.8M | −$133.2M | −22.88% |
| Q1 2025 | 2025-03-31 | $486.5M | −$24.4M | −4.77% |
| Q4 2024 | 2024-12-31 | $526.3M | $57.1M | +12.18% |
| Q3 2024 | 2024-09-30 | $554.6M | $69.6M | +14.34% |
| Q2 2024 | 2024-06-30 | $582.0M | $88.0M | +17.81% |
| Q1 2024 | 2024-03-31 | $510.8M | $35.3M | +7.42% |
| Q4 2023 | 2023-12-31 | $469.2M | $217.1M | +86.15% |
| Q3 2023 | 2023-09-30 | $485.0M | $210.6M | +76.72% |
| Q2 2023 | 2023-06-30 | $494.0M | $198.1M | +66.93% |
| Q1 2023 | 2023-03-31 | $475.6M | $158.9M | +50.16% |
| Q4 2022 | 2022-12-31 | $252.1M | −$53.8M | −17.58% |
| Q3 2022 | 2022-09-30 | $274.5M | $142.1M | +107.31% |
| Q2 2022 | 2022-06-30 | $295.9M | — | — |
| Q1 2022 | 2022-03-31 | $316.7M | — | — |
| Q4 2021 | 2021-12-31 | $305.8M | $262.3M | +602.63% |
| Q3 2021 | 2021-09-30 | $132.4M | — | — |
| Q4 2020 | 2020-12-31 | $43.5M | — | — |
Entrada Therapeutics total assets trends
Over the last five fiscal years, Entrada Therapeutics's total assets increased from $43.5M to $377.4M, a change of $333.9M. The latest reported quarter, Q2 2026, shows $298.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entrada Therapeutics source filings ↗